Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2014 2
2015 2
2016 1
2017 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Determinants of p16/Ki-67 adequacy and positivity in HPV-positive women from a screening population.
Benevolo M, Mancuso P, Allia E, Gustinucci D, Bulletti S, Cesarini E, Carozzi FM, Confortini M, Bisanzi S, Rubino T, Rollo F, Marchi N, Farruggio A, Pusiol T, Venturelli F, Giorgi Rossi P; New Technologies for Cervical Cancer 2 (NTCC2) Working Group. Benevolo M, et al. Cancer Cytopathol. 2021 May;129(5):383-393. doi: 10.1002/cncy.22385. Epub 2020 Nov 3. Cancer Cytopathol. 2021. PMID: 33142029 Free article.
Invitation strategies for colorectal cancer screening programmes: The impact of an advance notification letter.
Senore C, Ederle A, DePretis G, Magnani C, Canuti D, Deandrea S, Zorzi M, Barca A, Bestagini P, Faitini K, Bisanti L, Casale C, Ferro A, GiorgiRossi P, Quadrino F, Fiorina G, Capuano A, Segnan N, Fantin A. Senore C, et al. Among authors: quadrino f. Prev Med. 2015 Apr;73:106-11. doi: 10.1016/j.ypmed.2015.01.005. Epub 2015 Jan 17. Prev Med. 2015. PMID: 25602908 Clinical Trial.
Detection rate and predictive factors of sessile serrated polyps in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
Zorzi M, Senore C, Da Re F, Barca A, Bonelli LA, Cannizzaro R, de Pretis G, Di Furia L, Di Giulio E, Mantellini P, Naldoni C, Sassatelli R, Rex DK, Zappa M, Hassan C; Equipe Working Group. Zorzi M, et al. Gut. 2017 Jul;66(7):1233-1240. doi: 10.1136/gutjnl-2015-310587. Epub 2016 Feb 19. Gut. 2017. PMID: 26896459
Can colorectal cancer mass-screening organization be evidence-based? Lessons from failures: the experimental and pilot phases of the Lazio program.
Federici A, Barca A, Baiocchi D, Quadrino F, Valle S, Borgia P, Guasticchi G, Giorgi Rossi P; Colon-Rectal Cancer Screening Working Group. Federici A, et al. Among authors: quadrino f. BMC Public Health. 2008 Sep 19;8:318. doi: 10.1186/1471-2458-8-318. BMC Public Health. 2008. PMID: 18803810 Free PMC article.
Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
Zorzi M, Senore C, Da Re F, Barca A, Bonelli LA, Cannizzaro R, Fasoli R, Di Furia L, Di Giulio E, Mantellini P, Naldoni C, Sassatelli R, Rex D, Hassan C, Zappa M; Equipe Working Group. Zorzi M, et al. Gut. 2015 Sep;64(9):1389-96. doi: 10.1136/gutjnl-2014-307954. Epub 2014 Sep 16. Gut. 2015. PMID: 25227521
A comparison of different strategies used to invite subjects with a positive faecal occult blood test to a colonoscopy assessment. A randomised controlled trial in population-based screening programmes.
Zorzi M, Giorgi Rossi P, Cogo C, Falcini F, Giorgi D, Grazzini G, Mariotti L, Matarese V, Soppelsa F, Senore C, Ferro A; PARC Working Group. Zorzi M, et al. Prev Med. 2014 Aug;65:70-6. doi: 10.1016/j.ypmed.2014.04.022. Epub 2014 May 6. Prev Med. 2014. PMID: 24811759 Clinical Trial.